In multivariable external testing, tumor structure habitat phenotypes from pre-treatment MRI revealed more than a doubling of recurrence risk for women with stage 2 and stage 3 breast cancer.
|Articles|February 1, 2009
- Diagnostic Imaging Vol 31 No 2
- Volume 31
- Issue 2
Vertebroplasty data hint atnegative effect on survival
Researchers were stunned when preliminary results of an ongoing study showed that patients who undergo vertebroplasty may die sooner than patients with vertebral fractures who do not undergo the procedure.
Advertisement
Researchers were stunned when preliminary results of an ongoing study showed that patients who undergo vertebroplasty may die sooner than patients with vertebral fractures who do not undergo the procedure.
“It doesn’t make any sense to us,” said coauthor Dr. Robert J. McDonald from Mayo Clinic’s Medical Scientist Training Program.
McDonald and colleagues in Rochester, MN, compared survival rates of patients treated with vertebroplasty for vertebral fractures with those treated conservatively. A preliminary data analysis suggested the former had a significantly reduced life expectancy when compared with the latter.
The study remains a work-in-progress, however, and McDonald advised against jumping to conclusions before final results are in. He released the preliminary findings at the 2008 RSNA meeting.
Articles in this issue
over 17 years ago
International experts, cutting-edgetechnology impress RSNA newbieover 17 years ago
Radiology gets sent off to the washhouseover 17 years ago
Clinicians identify tacticsthat minimize risk of NSFover 17 years ago
Edgy NSF article may have gone too farover 17 years ago
Game changes with new portable and wireless digital radiographyover 17 years ago
Study confirms: Digitalmammo lengthens read timeover 17 years ago
Vampire bat thrombolytic study findings disappointover 17 years ago
Incidental finding on MRIpoints to multiple sclerosisover 17 years ago
3D neuro imaging techniquerealizes Orwellian visionover 17 years ago
Imaging utilization increaseswhere radiologists waneAdvertisement
Related to this article
Could a la carte pricing be a consideration in improving revenue for radiologists in private practice?
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Is Private Practice Radiology as Important as an Amusement Park?
3
Can MRI-Derived Tumor Habitat Subregions Bolster Recurrence Risk Stratification in Stage 2 and 3 Breast Cancer Cases?
4
Diagnostic Imaging’s Weekly Scan: September 13 — September 19
5